| Amy Irene Lucas, MSN, RN, CCNS, CCRNK | |
|
1906 Belleview Ave Se Ofc, 8w Cns Office, Roanoke, VA 24014-1838 | |
| (540) 224-2515 | |
| Not Available |
| Full Name | Amy Irene Lucas |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Critical Care Medicine |
| Location | 1906 Belleview Ave Se Ofc, Roanoke, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013477819 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Amy Irene Lucas, MSN, RN, CCNS, CCRNK 1906 Belleview Ave Se Ofc, 8w Cns Office, Roanoke, VA 24014-1838 Ph: (540) 224-2515 | Amy Irene Lucas, MSN, RN, CCNS, CCRNK 1906 Belleview Ave Se Ofc, 8w Cns Office, Roanoke, VA 24014-1838 Ph: (540) 224-2515 |
News Archive
Huntington's disease is an autosomal-dominant inherited neurodegenerative disease with a distinct phenotype, but the pathogenesis is unclear.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.
In an amusing but amazing turnaround, it seems the most foul-smelling compound on earth, called putrescine, could help relieve chronic inflammation, most importantly in the arterial thickening called atherosclerosis. This discovery is reported in the journal Cell Metabolism in January 2020.
The study, published by Cell Press in the January 15th issue of the journal Neuron, provides intriguing insight into how human behavior can be guided by the perceived behavior of other individuals.
› Verified 3 days ago
Martha Anderson, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2118 Rosalind Ave Sw, Roanoke, VA 24014 Phone: 540-981-7653 Fax: 540-981-7469 | |
Jill Bass, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2118 Rosalind Ave Sw, Roanoke, VA 24014 Phone: 540-981-7653 Fax: 540-981-7469 | |
Kimberly Ann Ramsey, MSN, ACCNS-N Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-266-6072 | |
Dr. Phyllis Brown Whitehead, PHD, CNS, ACHPN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-521-6048 Fax: 540-344-3641 | |
Mrs. Suzanne Hollen Beels, MSN, RN, AGCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1906 Belleview Ave Se Fl 6, Roanoke, VA 24014 Phone: 540-598-0356 | |
Ms. Donna Christine Bond, CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7133 Fax: 540-981-8643 | |
Dr. Ellen Marie Harvey, CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-581-4507 |